What Are Neurological Diseases?

Neurological diseases are disorders that affect the brain, spinal cord, and the peripheral nerves that form the nervous system. They encompass a broad spectrum of conditions ranging from acute traumatic injuries to chronic degenerative processes, and from congenital disorders to infectious diseases of neural tissue. The World Health Organization estimates that neurological conditions account for a significant portion of global disability, affecting hundreds of millions of people worldwide.

The nervous system's complexity makes it uniquely vulnerable: neurons have limited capacity for regeneration, and disruptions to axonal conduction, synaptic transmission, or myelin integrity can produce lasting functional deficits. Understanding neurological diseases requires integrating knowledge from molecular biology, neurophysiology, materials science, and clinical medicine.

Nervous System Disorders

Neurological diseases are broadly categorized according to which part of the nervous system is affected and the nature of the underlying pathology. Central nervous system (CNS) disorders affect the brain and spinal cord, while peripheral nervous system (PNS) disorders involve the cranial and spinal nerves outside the brain and cord. CNS diseases include conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. Peripheral neuropathies, by contrast, typically manifest as weakness, numbness, or pain in the extremities and arise from metabolic, toxic, or hereditary causes. Neurodegenerative diseases share a common mechanism in which specific neuronal populations progressively deteriorate, driven by protein aggregation, mitochondrial dysfunction, or neuroinflammation. Research published in PMC through NIH illustrates how advances in neurophysiology and neuroengineering are providing new windows into these mechanisms.

Spinal Cord Injury

Spinal cord injury (SCI) represents one of the most studied neurological conditions in biomedical engineering, because it creates a discrete, well-characterized lesion that severs descending and ascending tracts. Traumatic SCI results in immediate mechanical damage followed by a secondary cascade of ischemia, inflammation, and excitotoxicity. WHO data indicate that 250,000 to 500,000 people sustain spinal cord injuries annually worldwide. Recovery of function depends on the degree of sparing below the injury level, classified by the American Spinal Injury Association (ASIA) Impairment Scale. Engineering approaches to SCI include biomaterial scaffolds that bridge the lesion site and support axonal regrowth, as described in a review of biomaterials in peripheral nerve and spinal cord repair. Neuroprosthetic devices and epidural electrical stimulation have also demonstrated the ability to restore partial motor function in individuals with clinically complete injuries.

Engineering Approaches to Treatment

The intersection of electrical engineering and neurology has produced a generation of diagnostic and therapeutic tools. Electroencephalography (EEG), electromyography (EMG), and functional magnetic resonance imaging (fMRI) yield quantitative biomarkers of disease progression and treatment response. On the therapeutic side, deep brain stimulation (DBS) systems deliver continuous pulsed current to subcortical targets in Parkinson's disease and essential tremor, with some patients regaining substantial motor control. Closed-loop neurostimulation devices adapt stimulus parameters in real time based on sensed neural signals, a capability that requires tight integration between sensing circuits, signal processing algorithms, and implantable electronics. A NSF-DFG workshop report on neuroengineering and neurotechnologies outlines how bidirectional brain-computer interfaces could transform treatment of both traumatic and degenerative neurological conditions.

Applications

Neurological diseases research has applications in a range of fields, including:

• Implantable neural stimulation and prosthetic devices for motor rehabilitation
• Brain-computer interfaces for communication in locked-in patients
• Biomarker detection systems for early diagnosis of neurodegenerative conditions
• Rehabilitation robotics guided by EMG and EEG feedback
• Drug delivery platforms targeted to the blood-brain barrier